Redstart Labs to Increase Stake in Brainsight Technology for INR 3 Crore
Redstart Labs, a subsidiary of the prominent online classified company Info Edge, is set to acquire an additional stake in Brainsight Technology, a Bengaluru-based healthcare startup. The acquisition, valued at INR 3 crore (approximately $353,000), will increase Redstart’s shareholding in Brainsight from 4.68% to 5.27%. The decision to proceed with this investment follows approval from Redstart Labs’ board of directors, as disclosed in an official exchange filing.
About the Investment
The investment will be in the form of 385 compulsorily convertible preference shares (CCPS) of Brainsight Technology, which is engaged in the development of AI-based solutions for functional brain mapping. This move underscores Redstart Labs’ strategic focus on expanding its portfolio of cutting-edge technologies in the healthcare sector. The additional stake acquisition allows Info Edge’s subsidiary to deepen its involvement in the growing field of artificial intelligence in healthcare, particularly in functional brain mapping.
While the current stake of Redstart Labs in Brainsight is 4.68%, the increased investment will raise that to 5.27%. This decision to further invest in Brainsight aligns with the company’s broader interest in leveraging technology to transform healthcare practices. Redstart Labs’ involvement in Brainsight’s innovative healthcare solutions is a part of its larger push to support and invest in early-stage, high-growth startups in the technology and healthcare sectors.
Brainsight Technology: A Pioneer in Functional Brain Mapping
Founded in 2019 by Laina Emmanuel and Rimjhim Agrawal, Brainsight Technology specializes in AI-driven solutions that assist in the mapping of brain functions. By utilizing artificial intelligence, the company offers a deeper and more accurate understanding of brain activity, which has broad applications in neuroscience, medical research, and healthcare.
Brainsight’s flagship products, Voxelbox and Snowdrop, are specifically designed to provide advanced functional brain mapping solutions. Voxelbox is a tool that helps in the visualization and analysis of the brain’s structural and functional data, which is particularly beneficial for research and clinical purposes. Snowdrop, on the other hand, is focused on providing real-time data for clinical decision-making, offering healthcare professionals enhanced insight into brain function and helping them make more informed decisions for patient care.
These innovative products have placed Brainsight at the forefront of AI-based healthcare solutions, enabling healthcare professionals and researchers to conduct more precise diagnoses and interventions in areas related to brain health. Given the increasing demand for advanced brain mapping technologies, Brainsight’s AI-driven tools are expected to play a crucial role in the evolving landscape of medical diagnostics and brain research.
The Future of AI in Healthcare
The increasing integration of artificial intelligence in healthcare presents a promising future for startups like Brainsight. AI has the potential to revolutionize healthcare by enabling faster diagnoses, more personalized treatments, and improved patient outcomes. Functional brain mapping is one area where AI is making significant strides, allowing for better insights into neurological conditions such as epilepsy, stroke, and other brain disorders.
Info Edge’s continued investment through Redstart Labs highlights the growing interest in this sector, as AI-driven healthcare solutions are poised to become integral to modern medical practices. Redstart’s involvement in Brainsight is not just a financial investment but also a strategic partnership that could help the startup scale its technology and reach a broader market.
Conclusion
Redstart Labs’ decision to increase its stake in Brainsight Technology reflects a strong belief in the potential of AI-driven healthcare solutions. With Brainsight’s pioneering products like Voxelbox and Snowdrop, the company is well-positioned to make a significant impact in the field of functional brain mapping. This additional investment will not only solidify Redstart Labs’ presence in the healthcare sector but also contribute to the ongoing development of cutting-edge technology that could shape the future of brain health and diagnostics.
![BNP Paribas Makes Strategic Moves in Indian Markets with Bulk Deals in Eternal and Nykaa Worth Over INR 2,000 Cr]({"jaw_blog-16_9-small":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-15-170x170.jpg","width":170,"filesize":10850},"jaw_blog-16_9-middle":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-15-270x270.jpg","width":270,"filesize":21388},"jaw_blog-16_9":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-15-475x475.jpg","width":475,"filesize":46844}})
![Nykaa Q4 FY25 Results: Net Profit Soars 110% YoY, Revenue Up 24% Despite QoQ Dip]({"jaw_blog-16_9-small":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-14-170x170.jpg","width":170,"filesize":10162},"jaw_blog-16_9-middle":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-14-270x270.jpg","width":270,"filesize":20089},"jaw_blog-16_9":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-14-475x475.jpg","width":475,"filesize":44572}})
![Honasa Consumer (Mamaearth) Sees 18% Decline in Q4 Profit Despite Revenue Growth]({"jaw_blog-16_9-small":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-13-170x170.jpg","width":170,"filesize":10851},"jaw_blog-16_9-middle":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-13-270x270.jpg","width":270,"filesize":21702},"jaw_blog-16_9":{"file":"https:\/\/brandzmagazine.com\/wp-content\/uploads\/2025\/05\/brandzmagazine.com_-13-475x475.jpg","width":475,"filesize":48402}})